-- テリックス・ファーマシューティカルズ（ASX:TLX）は、開発中の画像診断薬TLX250-Pxが、淡明細胞型腎細胞癌（ccRCC）だけでなく、他の種類の腎癌の診断にも役立つ可能性を秘めていると、同社は火曜日に発表した。これは、欧州泌尿器科学誌に掲載された独立機関による分析結果を引用したものだ。 同社によると、第3相臨床試験データの分析では、PETスキャンで陽性所見が認められた場合、淡明細胞型腎細胞癌以外の腎癌を含む、悪性腫瘍全体を「非常に高い精度で予測」できることが示され、陽性予測値は98%だったという。 テリックス・グループの最高医療責任者であるデビッド・ケイド氏は、「ZIRCON試験でccRCCと診断された症例のほぼ全てが、実際には他の悪性腎癌のサブタイプであることが判明した。これにより、過剰治療のリスクが軽減され、臨床応用へのさらなる後押しとなる」と述べた。
Related Articles
Asia
Market Chatter: Billionaire Pamela Wall Said to Sell AU$300 Million Codan Shares in Block Trade
Codan's (ASX:CDA) largest individual shareholder, the billionaire Pamela Wall, is said to have approved a block trade, valued at around AU$300 million, the Australian Financial Review reported Tuesday, citing anonymous people involved in the transaction.Wall will retain around AU$1.2 billion in Codan shares after the reported sell down.Canaccord Genuity is said to be working on the trade. It is understood shares were being offered at about AU$39 each, per the report.(Market Chatter news is derived from conversations with market professionals globally. This information is believed to be from reliable sources but may include rumor and speculation. Accuracy is not guaranteed.)
$ASX:CDA
Asia
Great Boulder Resources Secures AU$40 Million in Two-Tranche Placement; Shares Up 19%
Great Boulder Resources (ASX:GBR) secured firm commitments to raise AU$40 million from institutional and sophisticated investors through a two-tranche placement, issuing around 470.6 million shares at AU$0.085 each, representing a discount of nearly 14% to its 10-day volume-weighted average price, according to a Tuesday filing with the Australian bourse.The first tranche is expected to raise about AU$12.4 million from 145.5 million shares, while the second tranche aims to generate around AU$27.6 million from 325.1 million shares, subject to shareholder approval, the filing said.The funds will be used to support the company's acquisition of the Peak Hill gold project from Aragon Resources, a wholly owned subsidiary of Westgold Resources (ASX:WGX), the filing added.The company's shares jumped 19% in recent Tuesday trade.
$ASX:GBR$ASX:WGX
Asia
Grab Attributable Profit Surges in Q1
Singapore-headquartered ride-hailing company Grab reported attributable profit of $136 million in the first quarter of the year from $24 million a year earlier, according to a company release on Tuesday.Basic earnings per share were $0.03 compared with EPS of $0.01 a year ago.Revenue climbed 24% year over year to $955 million from $773 million, backed by growth across the on-demand and financial services segments.
$^STI